Stock market today: Dow pops higher, Nasdaq and S&P 500 slide amid rate-cut fears

Published On Jan 13, 2025, 1:25 PM

Stocks were mixed on Monday, with major declines in tech stocks such as Nvidia and Apple amidst rising bond yields and a strong U.S. dollar, leading to concerns over interest rate cuts by the Federal Reserve. The S&P 500 fell 0.3% and the Nasdaq Composite dropped 0.8%, while the Dow Jones Industrial Average managed to rise 0.5%. Additionally, oil prices climbed to five-month highs following new sanctions on Russian crude. Moderna's stock experienced a significant drop of 23% after the company revised its 2025 sales forecast downwards due to weak vaccine demand.

Stock Forecasts

NVDA

Negative

The mixed performance of the stock market suggests volatility, especially in the tech sector which is heavily influenced by interest rate expectations and bond yields. Tech stocks like Nvidia and Apple faced declines due to fading optimism about rate cuts, although more stable sectors like utilities and health care seem to benefit. However, rising oil prices could impact consumer spending and overall inflation, raising further concerns for tech valuation.

XLE

Positive

Rising oil prices could be beneficial for energy stocks, as they are expected to benefit from supply concerns and higher prices. Brent crude exceeding $81 per barrel is indicative of tighter supply and increased demand, particularly in Asia. This trend may lead to bullish sentiment in the energy sector moving forward.

MRNA

Negative

The decline in Moderna's stock following a bleak sales forecast indicates a negative short-term sentiment towards biotech stocks, especially those heavily reliant on pandemic-related products. With demand decreasing, investors may seek to pull back from MRNA which could lead to further declines unless new catalysts surface.

Related News

Moderna shares slumped Monday on the companies downgraded 2025 outlook

Stocks are under pressure as strong data craters bets on the chances of Fed rate cuts.

NVDA
UNH
TSLA
MRNA

Stocks are under pressure as strong data craters bets on the chances of Fed rate cuts.

NVDA
UNH
MRNA